Chill Pill™ offers precision dosing and superior bioavailability for fast, reliable effects; fills a hole in the Arizona cannabis market as competitor closes.
PAYSON, Ariz. (July 28, 2023) – Ally Biotech, a science-based company and provider of leading-edge bioactive delivery solutions for cannabinoids, today announces that, with the exit of a top competitor, their Chill Pill line of product will see new innovative products releasing throughout the fall of 2023, filling the gap in the Arizona soft gel marketplace.
The Arizona-based Chill Pill brand, an expansive line of easy-to-swallow THC soft gels, is available in dozens of dispensaries across the state, and has been a renowned and award winning soft gel brand in Arizona for almost a decade.
The cannabis capsule marketplace is experiencing exponential growth and is expected to continue to grow an estimated 18 percent by 2027, according to Data Bridge Market Research.
Available in a variety of strengths and strains, with effects ranging from highly responsive to highly relaxed, Chill Pill soft gels offer consumers better options to control onset timing, intensity and duration of desired effects. In addition, Chill Pill THC soft gels provide precise dosing, measured twice, once before encapsulation and once after the soft gel is created, resulting in higher quality, more consistent products.
“Between filling a gap in the Arizona cannabis marketplace and predicted continued growth of the cannabis capsule, Chill Pill is poised to be a market leader in the soft gel category,” said Francis Baczek, V.P of Business Development at Ally Biotech.
“Chill Pill stands out against other edible consumption methods with their precision dosing. Consumers are looking for smokeless, rapid-onset products that are consistent. The Chill Pill line is a sugar-free formulation, and is a better way to dose for many.”
The Chill Pill soft gels line offers a variety of formulations including:
● Day Caps – a CBG and sativa dominant formula.
● Anytime Caps – a hybrid formulation that combines sativa and indica.
● Night Caps – a CBN and indica dominant formula.
● Anytime Caps + CBD – a 1:1 blend of THC and CBD.
● THC-A – Non-intoxicating symptom relief with no psychoactive effects.
Baczek added that, due to the continuous growth in demand, plans are in the works to expand the Chill Pill brand’s line of products. Ally Biotech acquired the Chill Pill brand just this past spring. For more information on Ally Biotech, visit AllyBiotech.com. For more information about the Chill Pill, visit ChillPillsAZ.com.
About Ally Biotech:
Headquartered in Payson, Arizona, Ally Biotech offers highly bioavailable products to leading manufacturers and dispensaries of cannabis products since 2019 The company recently acquired the Chill Pill line of products. The company’s Lipofusion® delivery technology combines nanotechnology and liposomal science to speed product differentiation and innovation. Ally Biotech offers product development services, and manufacturing-ready, water soluble Lipofusion THC that can be utilized as a raw ingredient in powder or liquid form in a variety of products. All of the company’s products undergo rigorous testing for purity, potency, safety and efficacy at third-party laboratories. For more information, visit AllyBiotech.com. For more information about the Chill Pill, visit ChillPillsAZ.com.
About Chill Pill:
The Arizona-based Chill Pill brand is an expansive line of easy-to-swallow THC soft gels for the cannabis industry. Formulated using hemp seed oil, Chill Pills are easy to absorb, metabolize, and come in a variety of strengths and strains, with effects ranging from highly responsive to highly relaxed. Chill Pill is owned and operated by Ally Biotech, a company committed to harnessing the power of science to create innovative THC products, such as their patented Lipofusion® technology. For more information, visit ChillPillsAZ.com.